SE0103858D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
SE0103858D0
SE0103858D0 SE0103858A SE0103858A SE0103858D0 SE 0103858 D0 SE0103858 D0 SE 0103858D0 SE 0103858 A SE0103858 A SE 0103858A SE 0103858 A SE0103858 A SE 0103858A SE 0103858 D0 SE0103858 D0 SE 0103858D0
Authority
SE
Sweden
Prior art keywords
pharmaceutically acceptable
precursors
mammal
pharmaceutical composition
compound selected
Prior art date
Application number
SE0103858A
Other languages
English (en)
Swedish (sv)
Inventor
Stephen P Arneric
Per-Olof Andersson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of SE0103858D0 publication Critical patent/SE0103858D0/xx
Priority to CNA028188764A priority Critical patent/CN1558756A/zh
Priority to BR0212824-1A priority patent/BR0212824A/pt
Priority to EP02775633A priority patent/EP1438035A2/en
Priority to MXPA04002496A priority patent/MXPA04002496A/es
Priority to PCT/SE2002/001748 priority patent/WO2003026564A2/en
Priority to CA002461731A priority patent/CA2461731A1/en
Priority to KR10-2004-7004529A priority patent/KR20040039436A/ko
Priority to JP2003530203A priority patent/JP2005503424A/ja
Priority to IL16085202A priority patent/IL160852A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0103858A 2001-09-27 2001-11-20 Pharmaceutical composition SE0103858D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CNA028188764A CN1558756A (zh) 2001-09-27 2002-09-26 用于治疗泌尿疾病的药物组合物
BR0212824-1A BR0212824A (pt) 2001-09-27 2002-09-26 Composição farmacêutica
EP02775633A EP1438035A2 (en) 2001-09-27 2002-09-26 Pharmaceutical compositions for the treatment of urinary disorders
MXPA04002496A MXPA04002496A (es) 2001-09-27 2002-09-26 Composicion farmaceutica para el tratamiento de enfermedades urinarias.
PCT/SE2002/001748 WO2003026564A2 (en) 2001-09-27 2002-09-26 Pharmaceutical compositions for the treatment of urinary disorders
CA002461731A CA2461731A1 (en) 2001-09-27 2002-09-26 Pharmaceutical compositions for the treatment of urinary disorders
KR10-2004-7004529A KR20040039436A (ko) 2001-09-27 2002-09-26 약학 조성물
JP2003530203A JP2005503424A (ja) 2001-09-27 2002-09-26 尿疾患の治療用医薬組成物
IL16085202A IL160852A0 (en) 2001-09-27 2002-09-26 Pharmaceutical compositions for the treatment of urinary disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/965,556 US20030060513A1 (en) 2001-09-27 2001-09-27 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
SE0103858D0 true SE0103858D0 (sv) 2001-11-20

Family

ID=25510135

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0103858A SE0103858D0 (sv) 2001-09-27 2001-11-20 Pharmaceutical composition

Country Status (4)

Country Link
US (2) US20030060513A1 (pl)
PL (1) PL370037A1 (pl)
SE (1) SE0103858D0 (pl)
ZA (1) ZA200402362B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
AU2003265680A1 (en) * 2002-08-28 2004-03-19 Pharmacia Corporation Oral liquid tolterodine composition
TW200800959A (en) * 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
EP2026783A2 (en) * 2006-06-09 2009-02-25 Wyeth a Corporation of the State of Delaware Method for enhancing cognitive function
US8871275B2 (en) 2007-08-08 2014-10-28 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
EP2042179A1 (en) * 2007-09-26 2009-04-01 sanofi-aventis Novel therapeutic uses of adrenergic alpha-1 receptor antagonists
ES2923438T3 (es) * 2014-11-20 2022-09-27 Serenity Pharmaceuticals Llc Composiciones que comprenden bajas dosis de desmopresina en combinación con un antagonista del receptor alfaadrenérgico
HRP20241412T1 (hr) 2018-01-30 2024-12-20 Apnimed, Inc. (Delaware) Postupci i pripravci namijenjeni liječenju apneje u snu ili običnog hrkanja

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US5382600A (en) * 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
SE9203318D0 (sv) * 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence

Also Published As

Publication number Publication date
US20030060513A1 (en) 2003-03-27
PL370037A1 (pl) 2005-05-16
US20040116533A1 (en) 2004-06-17
ZA200402362B (en) 2005-01-20

Similar Documents

Publication Publication Date Title
RU2001133004A (ru) Применение селективных антагонистов альфа1b-адренергического рецептора для улучшения состояния при сексуальной дисфункции
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
TW200642685A (en) Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
UA74391C2 (uk) Арил- або гетероарилконденсовані імідазоли як антизапальні і анальгетичні агенти
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
EA200700232A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
RU2002121646A (ru) 1,3-дизамещенные пирролидины в качестве антагонистов альфа-2-адренорецепторов
PE20030347A1 (es) Composiciones farmaceuticas, kits y procedimientos que comprenden combinaciones de agonistas/antagonistas de estrogenos, estrogenos y progestinas
BR0108816A (pt) Derivados de quinolina como antagonistas alfa-2
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
SE9903997D0 (sv) New compounds
SE0102055D0 (sv) New Compounds
DK1230236T3 (da) Forbindelse med væksthormonfrigörende egenskaber
PT1336407E (pt) Composicao contendo um antagonista do receptor de angiotensina e um diuretico e sua utilizacao para o tratamento da hipertensao
MXPA04002496A (es) Composicion farmaceutica para el tratamiento de enfermedades urinarias.
DE60120962D1 (de) Substituierte chalkone als arzneimitteln
DE69533194D1 (de) PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN
TNSN06278A1 (en) [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase
EP1453507A4 (en) SOLUBILIZED TOPOISOMERASE GIFT MEDIUM
ATE390923T1 (de) Topoisomerase-giftmittel
CA2364178A1 (en) N-benzenesulfonyl l-proline compounds as bradykinin antagonists
IL160082A0 (en) Quinoline derivatives and use thereof as antitumor agents
WO2005021040A3 (en) Compositions useful for treating gastrointestinal motility disorders